In This Article:
The French market has been experiencing robust gains, with the CAC 40 Index advancing by 2.48% amid growing hopes for interest rate cuts. This positive economic sentiment provides a fertile ground for growth companies, particularly those with significant insider ownership, which often signals strong confidence in the business's future prospects. When evaluating stocks in such a favorable market environment, it's crucial to consider companies that not only exhibit high growth potential but also have substantial insider ownership. This combination can indicate alignment between management and shareholder interests, potentially leading to more prudent and strategic decision-making.
Top 10 Growth Companies With High Insider Ownership In France
Name | Insider Ownership | Earnings Growth |
Groupe OKwind Société anonyme (ENXTPA:ALOKW) | 24.8% | 36% |
VusionGroup (ENXTPA:VU) | 13.4% | 25.7% |
Adocia (ENXTPA:ADOC) | 11.9% | 63% |
Icape Holding (ENXTPA:ALICA) | 30.2% | 35.1% |
Arcure (ENXTPA:ALCUR) | 21.4% | 27.5% |
La Française de l'Energie (ENXTPA:FDE) | 19.9% | 31.9% |
S.M.A.I.O (ENXTPA:ALSMA) | 17.3% | 35.2% |
Munic (ENXTPA:ALMUN) | 29.2% | 149.2% |
OSE Immunotherapeutics (ENXTPA:OSE) | 25.6% | 5.9% |
MedinCell (ENXTPA:MEDCL) | 15.8% | 71.1% |
Below we spotlight a couple of our favorites from our exclusive screener.
MedinCell
Simply Wall St Growth Rating: ★★★★★☆
Overview: MedinCell S.A. is a pharmaceutical company in France that develops long-acting injectables across various therapeutic areas, with a market cap of €511.36 million.
Operations: MedinCell's revenue primarily comes from its pharmaceuticals segment, totaling €11.95 million.
Insider Ownership: 15.8%
Earnings Growth Forecast: 71.1% p.a.
MedinCell, a French growth company with high insider ownership, is expected to see substantial revenue growth at 44.7% per year, significantly outpacing the French market's 5.8%. Despite reporting a net loss of €25.04 million for the fiscal year ending March 31, 2024, down from €32.01 million the previous year, MedinCell's earnings are forecasted to grow by 71.06% annually and become profitable within three years. The stock trades at an estimated fair value discount of 87.2%.
-
Click here to discover the nuances of MedinCell with our detailed analytical future growth report.
-
Our valuation report unveils the possibility MedinCell's shares may be trading at a premium.
OVH Groupe
Simply Wall St Growth Rating: ★★★★☆☆
Overview: OVH Groupe S.A. offers public and private cloud services, shared hosting, and dedicated server solutions globally, with a market cap of €1.12 billion.